Effects of Age on Serum Dehydroepiandrosterone Sulfate, IGF-I, and IL-6 Levels in Women

[1]  E. Goodman,et al.  Changes in Bone Turnover Markers and Menstrual Function After Short‐term Oral DHEA in Young Women with Anorexia Nervosa , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  J. Glowacki,et al.  CHAPTER 15 – Sex Steroids, Bone, and Aging , 1999 .

[3]  D. Kiel,et al.  Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. , 1998, The Journal of clinical endocrinology and metabolism.

[4]  E. Barrett-Connor,et al.  Gender Differences in Insulin‐like Growth Factor and Bone Mineral Density Association in Old Age: The Rancho Bernardo Study , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  J. Schölmerich,et al.  Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. , 1998, The Journal of clinical endocrinology and metabolism.

[6]  B. Riggs,et al.  Estrogen Effects on Insulin-Like Growth Factor Gene Expression in a Human Osteoblastic Cell Line with High Levels of Estrogen Receptor , 1998, Calcified Tissue International.

[7]  E. Barrett-Connor,et al.  Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  J. Glowacki,et al.  Effects of age and estrogen status on the skeletal IGF regulatory system. Studies with human marrow. , 1997, Endocrine.

[9]  R. Daynes,et al.  Dysregulation of IL-10 production with aging: Possible linkage to the age-associated decline in DHEA and its sulfated derivative , 1996, Experimental Gerontology.

[10]  M. Testa,et al.  Reproducibility of DXA absorptiometry: A model for bone loss estimates , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  H. Broxmeyer,et al.  Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. , 1995, The Journal of clinical investigation.

[12]  N. Binkley,et al.  Elevated Plasma Levels of Interleukin‐6 in Postmenopausal Women Do Not Correlate with Bone Density , 1995, Journal of the American Geriatrics Society.

[13]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[14]  J. Goméz,et al.  Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. , 1994, The Journal of clinical endocrinology and metabolism.

[15]  S. Yen,et al.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. , 1994, The Journal of clinical endocrinology and metabolism.

[16]  R. Klopp,et al.  Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. , 1993, Lymphokine and cytokine research.

[17]  R. Daynes,et al.  Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. , 1993, Journal of immunology.

[18]  W. Ershler,et al.  Interleukin‐6: A Cytokine for Gerontolgists , 1993, Journal of the American Geriatrics Society.

[19]  E. Barrett-Connor,et al.  A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women. , 1993, American journal of epidemiology.

[20]  H. Broxmeyer,et al.  Increased osteoclast development after estrogen loss: mediation by interleukin-6. , 1992, Science.

[21]  Haimin Xu,et al.  Increase of plasma IL-6 concentration with age in healthy subjects. , 1992, Life sciences.

[22]  S. Yen,et al.  The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. , 1990, The Journal of clinical endocrinology and metabolism.

[23]  A. Vermeulen,et al.  Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopause. , 1989, Maturitas.

[24]  M. Horowitz,et al.  The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women. , 1985, The Journal of clinical endocrinology and metabolism.

[25]  N. Orentreich,et al.  Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. , 1984, The Journal of clinical endocrinology and metabolism.

[26]  C. Migeon,et al.  Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; day-to-day and diurnal variations. , 1957, The Journal of clinical endocrinology and metabolism.